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The development of the neonatal gastrointestinal tract microbiota remains a poorly
understood process. The interplay between neonatal (gestational age, genetic
background), maternal (mode of delivery, nutritional status) and environmental factors
(antibiotic exposure, available nutrition) are thought to influence microbial colonization,
however, the exact mechanisms are unclear. Derangements in this process likely
contribute to various gastrointestinal diseases including necrotizing enterocolitis and
inflammatory bowel disease. As such, enhanced understanding of microbiota
development may hold the key to significantly reduce the burden of gastrointestinal
disease in the pediatric population. The most debatable topics during microbial seeding
and possible future treatment approaches will be highlighted in this review.
Keywords: microbiome, microbiota, fetus, newborn, infant
INTRODUCTION
Humans are “holobionts”, which means that they host an assembly of their own human eukaryotic
cells and all of the microorganisms living in/on them (Meyer-Abich, 1943; Margulis and Fester,
1991). It is well established that the human microbiota comprises a wide array of microorganisms
including bacteria, archaea, fungi, and protozoa. The entirety of their corresponding genes are
referred by the term “microbiome” as reviewed by Lynch et al. (Lynch and Pedersen, 2016). Because
viruses are hosted in eukaryotic cells, bacteria or archaea, they are included under the umbrella of
the microbiome as well (Virgin, 2014). Metagenomic data and new bioinformatic tools help to
detect these hidden viral nucleotide sequences which may influence host phenotype (Angly et al.,
2005; Virgin and Todd, 2011). The largest microbiota of the human body is found in the
gastrointestinal tract (GIT) with about 1013–1014 microorganisms (Sender et al., 2016). As a
nutritional inflow source, the GIT represents a fertile ground for microbial colonization. However,
what types of microorganisms persist and in what quantity they do so, relies upon the methods by
which microorganisms extract energy and provide commensal benefit to the GIT. The challenge of
the host immune system is to both accept these commensal bacteria and defend against pathogens
(Round and Mazmanian, 2009; Kim and Claud, 2019). Not only do resident microbiota extract
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energy for their survival, but they can also support the GIT in its
function including pathogen defense (Freter, 1955; Abt and
Pamer, 2014), strengthening the intestinal barrier function
(Rakoff-Nahoum et al., 2004; Hayes et al., 2018) and
promoting the immune development (O’Mahony et al., 2006;
Round and Mazmanian, 2009). Additionally, the GIT microbiota
helps to digests nutrients and improves gut motility (Abrams and
Bishop, 1967; Dimidi et al., 2017) while supporting the synthesis
of essential fatty acids (Høverstad and Midtvedt, 1986), amino
acids (Jimenez et al., 2005), vitamins (Gustafsson et al., 1962) and
hormones (Yano et al., 2015; Martin et al., 2019).
Existing literature suggests that children who are vaginally
delivered at term without any instrumental assistance and are fed
with maternal breast milk have the best chance to develop a
healthy gastrointestinal microbiota which prevents dysbiosis
(Levin et al., 2016; Martin et al., 2016). Dysbiosis refers to a
phenomenon of microbiota “imbalance” or degeneracy in the
microorganism make-up, which is thought to be associated with
a wide range of metabolic/GIT diseases including obesity and
metabolic syndrome (Turnbaugh et al., 2009), type 1 diabetes
(Kostic et al., 2015), atopic conditions (Kalliomaki et al., 2001),
inflammatory bowel disease (IBD) (Gevers et al., 2014), and
necrotizing enterocolitis NEC (Fundora et al., 2020). As such,
further understanding of dysbiosis is the first step to not only
potentially prevent disease but also to offer hope for therapy.
This review summarizes the current evidence on the development
of microbial colonization with a focus on factors which have been
associated with dysbiosis including gestational age, mode of delivery,
nutrition and antibiotic therapy.
FIRST MICROBIAL COLONIZATION
The initiation of microbial colonization remains a controversial
topic in developmental biology. The theory of “sterile womb”
purports that the healthy fetus develops in a sterile environment
in utero (Th and Bettelheim, 1988) and that microbial
colonization starts after birth with the exception of intra-
uterine infections during pregnancy (Küstner, 1877; Tissier,
1900). This theory has been challenged when microbial
components have been detected in the placenta (Aagaard et al.,
2014; Collado et al., 2016) amniotic fluid (Collado et al., 2016),
umbilical cord blood (Jimenez et al., 2005), meconium (Jimenez
et al., 2008; Chu et al., 2017; Tapiainen et al., 2018), and fetal
membranes (Steel et al., 2005), even after uncomplicated
pregnancies with healthy term born newborns (Perez-Munoz
et al., 2017; Stinson et al., 2019; Patton and Neu, 2020). These
microbial particles have typically been detected by sensitive
polymerase chain reaction (PCR) methods. 16S ribosomal
RNA is derived from the prokaryotic ribosome and is used to
attribute detected RNA to respective bacterial strains (Woese and
Fox, 1977). In all these studies, PCR mean copy numbers were
low. Lauder et al. reported 5.72 × 102 gene copies for the
maternal side and 1.2 × 102 for the fetal side in samples which
were extracted from 0.1–0.5 g placental tissue (Lauder et al.,
2016). When Rackaityte et al. aimed to control for procedural
and environmental contamination, they found only 23.5
operational taxonomic units (OTUs) with ≥5 sequence read
counts per meconium sample. Additionally, they analyzed the
intestines of early terminated pregnancies (20 ± 2.2 weeks of
gestation) and detected bacterial structures on electron scans
(Rackaityte et al., 2020). Several sources of microbial fetal
encounters have been proposed including ascension from the
genitourinary tract (Zervomanolakis et al., 2007) or passage via
mucosal membranes such as the oral cavity or the GIT (Han
et al., 2004) of pregnant women (Baker et al., 2018). The analysis
of potential bacterial seeding in utero is heavily complicated by
intraamniotic infection. This infection occurs with an incidence
of 3.9% of all women giving birth (Woodd et al., 2019). It may
initially appear clinically silent but increases one’s risk of preterm
birth (Hillier et al., 1988). Joint diagnosis of histological
chorioamnionitis and bacterial growth in amnion cultures was
found to be as low as 27.7% (Queiros da Mota et al., 2013), that is
why detection of placental microbial particles could also
represent clinically inapparent infections.
Defenders of the sterile womb hypothesis attribute the
detected microbial particles to contamination (Olomu et al.,
2020), because there was no evidence of viability of the
detected bacterial structures (Rackaityte et al., 2020). Lim et al.
found neither microbial nor viral communities in their amnion
fluid samples from healthy term pregnancies (Lim et al., 2018;
Lim et al., 2019). Correspondingly, in healthy pregnancies, the
attempts to cultivate viable bacteria from placental specimen has
thus far failed (Kuperman et al., 2020). Additionally, recent
placental analyses of more than 500 placental tissue specimen
assessed both with 16S- and metagenomic analyses revealed that
besides pathogens (B streptococci), no placental microbiome has
been detectable (de Goffau et al., 2019).
An interesting theory, which may help to join the two
conflicting observations is that particles derived from bacteria,
fungi or viruses can be transported via the placenta to various
fetal sites and thereby contribute to the priming of the fetal
immune system (Wilcox and Jones, 2018). Microbial structures
might then occasionally be detected depending on the sensitivity
of the method.
It has been demonstrated that bacteria, as part of the maternal
microbiota can be absorbed by immune cells (Rescigno et al.,
2001). In theory, they could be transported via the blood stream
or the lymphatic system into the placenta (Funkhouser and
Bordenstein, 2013). Taking into account the immunological
challenge at the maternal-fetal interface of the placenta (Ander
et al., 2019), we suspect that there is also the possibility, that dead
bacterial components are expressed on placental dendritic cells
and may be taken over to the fetal side to prime the fetal immune
system as suspected for allergens (Szepfalusi et al., 2000).
However, the number of microbial agents which have been
described in placental tissue remains low. Tenericutes,
Firmicutes (Lactobacillus), Actinobacteria (Bifidobacterium,
Propionibacterium, Rhodococcus, Streptomyces), Bacteroidetes
(Bacteroides, Prevotella), Proteobacteria (E. coli, Neisseria,
Enterobacteria), and Fusobacteria have been found in the
placenta of healthy newborns at term (Aagaard et al., 2014;
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Parnell et al., 2017). Most taxa presented as “placental
microbiome” correspond to the taxa found in the maternal
oral microbiome (Fardini et al., 2010; Aagaard et al., 2014).
Furthermore, it has been suggested that oral infections such as
periodontitis are linked to complicated pregnancies and may
contribute to prematurity or neonatal sepsis as reviewed by Zi
et al. (2014).
With regard to umbilical cord blood of healthy term newborns
Actinobacteria (Bifidobacterium, Propionibacterium), Proteobacteria
(Escherichia), Firmicutes (Enterococcus, Staphylococcus,
Streptococcus), and Bacteroidetes (Bacteroides) have been detected
(Jimenez et al., 2005). Similarities between the microbiota of
meconium, placenta, and amnion fluid of healthy infants either
suggest a certain prenatal microbial antigen transfer or a common
source of contamination. However, Chu et al. describe different
bacteria on the newborn skin, mouth and nose depending on the
mode of delivery (Chu et al., 2017). Contrastingly, they found similar
bacteria in the newborn meconium with many samples harboring
highly abundant Escherichia and Klebsiella (abundance 14.3% and
6.4%, respectively), not detectable in any other body site, speculating
for a different microbial source prior to birth. It is tempting to assume
that immunological priming with microbial particles starts to shape
the fetal immune system prior to birth (Chu et al., 2017). Despite
numerous papers published on this field, the concerns of
contamination remain unsolved. In the newest study investigating
this issue, evidences were put forward for contamination as the origin
of bacteria found in human placenta samples (Gschwind et al., 2020).
INFLUENCE OF GESTATIONAL AGE
It has been well demonstrated that prematurity (birth before the
completion of 37 weeks of pregnancy) may be triggered by
intrauterine infections. Inflamed leaky or ruptured membranes
facilitate the ascension of bacteria from the genitourinary tract
(Hillier et al., 1995; Leitich et al., 2003). The gastrointestinal tract of
premature infants is also known to have leaky barrier properties
with a higher transepithelial and -mucosal permeability (Weaver
et al., 1984a; Weaver et al., 1984b), impaired motility (Berseth,
1996), less active digestive enzymes (Demers-Mathieu et al., 2018)
and lower absorption of nutrients (Neu and Koldovsky, 1996).
Compared to their term counterparts, the immune system of
premature infants displays fewer amounts of leukocytes, less
proinflammatory cytokines, and less antibacterial peptides (Strunk
et al., 2011; Melville and Moss, 2013).
Furthermore, preterm delivery is often linked to complicated
pregnancies with a higher rate of caesarian sections and the use
of prenatal antibiotics (Hill et al., 2017; Salvatore et al., 2019).
The less mature newborns are, the longer time they have to spend
in the neonatal intensive care unit (NICU) (Maier et al., 2018).
They receive parenteral nutrition and/or enteral nutrition via
nasogastric tubes (Viswanathan and Jadcherla, 2019).
Additionally, these infants often need respiratory support (Shi
et al., 2020). As a result of these well described, common
consequences of prematurity, preterm infants often have a
delayed development of their gastrointestinal bacterial microbiota,
a lower bacterial load (Chernikova et al., 2018), fewer commensals,
and obligate anaerobic bacteria and a higher number of pathogens
such as Klebsiella pneumoniae and Clostridium difficile and
facultative anaerobic bacteria (Dahl et al., 2018). The dominating
taxa consist of Firmicutes (Staphylococcus, Enterococcus),
Proteobacteria (Enterobacteriaceae, Escherichia, Klebsiella),
Actinobacteria, and Bacteroidetes (Bacteroides) (Patel et al., 2016;
Yuan et al., 2019). Their term counterparts are colonized with
predominantly Actinobacteria (Bifidobacterium) (Penders et al.,
2006) and Firmicutes (Staphylococcus, Streptococcus) (Palmer
et al., 2007).
These microbial changes in the preterm infant may be
associated with feeding intolerance (Ford et al., 2019; Salvatore
et al., 2019), NEC (Baranowski and Claud, 2019), late-onset
sepsis (LOS) (Stewart et al., 2017), and inferior long-term
neurological outcomes (Niemarkt et al., 2019). Even if
premature infants meet the «optimal microbial conditions»
including vaginal delivery, nutrition with breast milk and no
antibiotic therapy, the premature microbiome differs from the
microbiome of term neonates (Leitich et al., 2003; Penders et al.,
2006; Palmer et al., 2007). However, currently, there is no consensus
concerning the exact time point when the microbiota of preterm
and term infants align, with different studies reporting a time range
between 4 months and 4 years (Dahl et al., 2018; Fouhy et al., 2019).
A recent study of 5–11-year old children including 51 former
preterm children (≤ 32 weeks of gestational age) could still find
an inflammatory gut profile in the preterm group. The differences
were attributed to a reduced gut phage richness (Jayasinghe
et al., 2020).
INFLUENCE OF MODE OF DELIVERY
The mode of delivery influences the newborn gastrointestinal
microbiota. During vaginal delivery, the infant’s GIT is colonized
with vaginal (Dominguez-Bello et al., 2010) and intestinal
(Makino et al., 2011; Makino et al., 2013) bacteria from the
mother. Consequently, the infant’s gastrointestinal microbiota is
dominated by Actinobacteria (Bifidobacterium, Atobium)
(Dominguez-Bello et al., 2010; Reyman et al., 2019; Shao et al.,
2019; Yang et al., 2019), Firmicutes (Lactobacillus, Megamonas)
(Dominguez-Bello et al., 2010; Kuang et al., 2016), Bacteroidetes
(Prevotella, Bacteroides, Parabacteroides) (Dominguez-Bello
et al., 2010; Wampach et al., 2018), Fusobacteria (Sneathia)
(Dominguez-Bello et al., 2010), and Proteobacteria (Shigella,
Escherichia) (Kuang et al., 2016; Wampach et al., 2018; Shao
et al., 2019; Yang et al., 2019). Most of these bacteria produce
short chain fatty acids (SCFA), which lower the luminal pH and
thereby inhibit the colonization of pathogens (Nagpal and
Yamashiro, 2018). It is suggested that compared to children
delivered via caesarean section, children after vaginal delivery
display a higher diversity (Akagawa et al., 2019), fewer
Staphylococci (Wampach et al., 2018) and C. difficile in their
microbiota (Adlerberth and Wold, 2009).
In contrast, birth by caesarean (C-) section is theorized to
interrupt the microbial transmission from the mother to child
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that occurs during vaginal birth (Backhed et al., 2015; Hill et al.,
2017). Consequently, the GIT will first be colonized with bacteria
present on the maternal skin (Akagawa et al., 2019) or in the
direct neonatal environment (Dominguez-Bello et al., 2010). The
intestinal microbiota after C-section is characterized by delayed
bacterial colonization (Martin et al., 2016) and reduced number/
diversity (Azad et al., 2013), but an increased number of
opportunistic pathogens related to the hospital environment
(Toscano et al., 2017a; Shao et al., 2019). After C-section the
neonatal microbiome of the GIT is dominated by Firmicutes
(Enterococcus, Staphylococcus, Streptococcus, Clostridium,
Veillonella) (Azad et al., 2013; Martin et al., 2016; Kuang et al.,
2016; Shao et al., 2019), and Proteobacteria (Klebsiella,
Enterobacter, Haemophilus) (Shao et al., 2019). In relation to
vaginal delivery, there are fewer Bacteroides, Bifidobacteria and
Lactobacillus as well as SCFA (Nagpal and Yamashiro, 2018),
and there is a general imbalance of the gut microbiome (Hoang
et al., 2020). These findings correlate with a higher intraluminal
pH and lower inhibition of pathogens (Nagpal and Yamashiro,
2018). There is some debate whether or not contractions might
help to increase the microbial transfer to the baby (Levin et al.,
2016; Shao et al., 2019) and how heavily the data is biased by
antibiotic use as recommended prior to skin incision (Gholitabar
et al., 2011). Mothers after C-section often additionally display a
lower breastfeeding rate (Hobbs et al., 2016). In summary, C-
section might be a contributing factor in the development of
dysbiosis. However, the treatment of newborns with gauze swabs
full of vaginal microbiota «vaginal seeding» did not show any
benefit on long term outcomes but harbors the risk of pathogen
transfer such as herpes, group B streptococci, Chlamydia
trachomatis, and Neisseria gonorrhoeae (Cunnington et al.,
2016; Haahr et al., 2018).
INFLUENCE OF NUTRITION
At the beginning of the 20th century, people realized that
increasing alarming mortality rates of newborns and infants
were associated with reduced rates of breastfeeding (Wolf,
2003). In the modern era, it is well understood that maternal
breastfeeding indeed significantly reduces newborn and infant
mortality and morbidity and contributes to maternal health (Ip
et al., 2007; Zhao et al., 2020). However, the reasons underlying
this association are more complex than initial theories related to
breast milk providing nutrients and reducing pathogen transfer.
Consequently, the composition of breastmilk and its influence on
microbial composition is a growing area of research (Hennet and
Borsig, 2016), not only due to the billion-dollar market linked
to formula.
Important drivers for microbial seeding in the infant gut are
pre- and probiotics in human breast milk (Sanders et al., 2019).
Prebiotics are food components, which are not digested by
human enzymes, but can be metabolized by certain bacteria,
promote their growth and contribute to the health benefits of the
host (Gibson and Roberfroid, 1995; Gibson, 1998; Gibson et al.,
2004). Human milk oligosaccharides (HMO) are prebiotics and
the third most common component of breast milk after lactose
and lipids (Urashima et al., 2012). The first HMO has been
described in 1954 as “bifidus factor” (Gyorgy et al., 1954a;
Gyorgy et al., 1954b; Gauhe et al., 1954). These HMOs are not
digested by pancreatic enzymes, but reach the colon intact, where
they promote the growth of Bifidobacteria, Bacteroides and
Lactobacillus (Marcobal et al., 2010; Thongaram et al., 2017).
The digestion of HMO produces SCFA (such as acetate,
propionate and butyrate), which can be used as energy source
and lower the luminal pH, which inhibits the colonization of
pathogens (Yu et al., 2013; David et al., 2014). Interestingly,
the amount of specific fucosyl-oligosaccharides secreted into the
milk seems to depend on the genetic background of the mother
and whether it is preterm- or term breastmilk (Gabrielli et al.,
2011). In addition to lipids and carbohydrates, human breast
milk harbors proteins (immunoglobulins, enzymes) as well as
hormones, growth factors, nucleotides, leukocytes, cytokines,
lysozyme, and lactoferrin as reviewed by Hennet and Borsig
(2016). Breast-fed children have an intestinal microbiota mainly
dominated by Bifidobacteria and Lactobacilli (Cooke et al., 2005;
Backhed et al., 2015), Bacteroides (which can digest HMO) (Wang
et al., 2015) as well as Staphylococcus (Stewart et al., 2018). In
contrast, children drinking formula tend to have a higher bacterial
diversity and in addition to Bifidobacteriaceae, Clostridia,
Enterococcus, and Enterobacteriaceae are detected (Harmsen et al.,
2000; Li et al., 2014; Timmerman et al., 2017). However, studies are
inconsistent (Adlerberth andWold, 2009), possibly because they use
different analytical approaches and infant nutrition and
environmental influences are difficult to control in a large
infant cohort.
In addition to the benefits named above, nutrition based on
human milk is associated with a higher feeding tolerance
(Schanler et al., 1999), lower risk of NEC (Miller et al., 2018),
obesity (Ma et al., 2020), and atopic diseases (Lodge et al., 2015).
However, the studies analyzing newborn and infant nutrition
differ considerably concerning the duration and the amount of
human milk provided as well as whether children were
exclusively breastfed or human milk was provided with
the bottle.
Prebiotic supplements such as galacto- and fructo-
oligosaccharides added to infant formula shall mimic the effect
of natural HMOs (Lodge et al., 2015), but to date, have not been
demonstrated to lead to a complete approximation of the
newborn microbiota (Bakker-Zierikzee et al., 2005; Haarman
and Knol, 2005). In fact, intestinal microbiota of formula fed
infants had more potential pathogens (Benno et al., 1984;
Bezirtzoglou et al., 2011) as compared to breastfed children;
dominated by Firmicutes (Staphylococcus, Streptococcus,
Enterococcus, Lactobacillus, Clostridium), Bacteroidetes
(Bacteroides), Proteobacteria (Enterobacteria), and Actinobacteria
(Atopobium) (Fallani et al., 2010; Stewart et al., 2018). Probiotics are
substances that contain vital microorganisms, which confer health
benefits on their host (Food and Argiculture Organization of the
United Nations, 2002; Hill et al., 2014). These microorganisms may
change the microbial composition (Frese et al., 2017). They are
believed to improve the barrier function of the intestinal epithelia,
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modify the immune response and protect against pathogens due to
competition for nutrients and colonization with potential pathogens
(Servin, 2004; Athalye-Jape et al., 2018). It is hypothesized that the
supplementation of probiotics reduces the time to complete enteral
feeding (Samanta et al., 2009; Braga et al., 2011), the duration of
hospitalization (Romeo et al., 2011), and morbidity and mortality
(Barrington, 2011). Thebest evidence available in this regard involves
the combination of Bifidobacteria and Lactobacilli (Chang et al.,
2017). A recent Cochrane review on this topic found 24 trials
including 5,529 infants, all assessing probiotic treatment of
preterm infants <37 weeks gestational age or <2.500 g birth
weight. This meta-analysis found a significantly reduced
incidence of severe NEC (Bell stage II or more) relative risk (RR)
of 0.43 (95% confidence interval (CI) 0.33–0.56) and a reduced
mortality RR 0.65 (CI 0.52–0.81) (Hobbs et al., 2016). However,
the timing and composition of the probiotic treatment seems to be
very important, because both the combination of Lactobacillus
rhamnosus and Lactobacillus helveticus L (Freedman et al., 2018)
and the supplementation of Lactobacillus rhamnosus alone
were not sufficient to improve the outcome in children with
gastroenteritis (Schnadower et al., 2018). Experts therefore
suggest a personalized approach (Zmora et al., 2018).
While cultivated bacteria from breast milk samples have been
attributed to contamination (Dudgeon and Jewesbury, 1924;
Wright, 1947), living non-pathogenic bacteria below a density of
105 colony forming units/ml are now considered to be within
normal range (Weaver et al., 2019), and potentially beneficial to
newborn health (Toscano et al., 2017b). Several analyses have
detected living bacteria such as Firmicutes (Staphylococcus,
Streptococcus, Peptostreptococcus, Enterococcus, Clostridia,
Lactobacillus), Actinobacteria (Bifidobacterium, Corynebacterium),
Bacteroidetes (Bacteroides), and Proteobacteria (Escherichia,
Serratia, Pseudomonas) in human breast milk. With the
possibilities of large scale metagenomic analyses, it has now
become possible to track the potential transfer of mobile genetic
elements and antibiotic resistance genes via breast milk (Parnanen
et al., 2018). Additionally, viable fungi have been cultured from
breast milk samples recently at a density of ≥103/ml with the highest
rate of Malassezia, Candida, and Saccharomyces taxae (Boix-
Amoros et al., 2017). Vertical viral transmission from the mother
to her newborn is evident for cytomegalovirus (CMV) (Bardanzellu
et al., 2019), human immunodeficiency virus (HIV) (Van de Perre
et al., 2012), and human-T-lymphotrope virus (HTLV). However,
in general, breast-feeding has been associated with a lower risk of
viral infections (Arifeen et al., 2001; Bahl et al., 2005). This viral
reduction parallels with the finding, that prophages are also more
abundant in formula-fed infants (Liang et al., 2020). There is a
currently contentious debate in this regard to where microbial
particles found in the human breast milk derive from and why
microbial loads are reported to be divers (Biagi et al., 2017).
Potential sources include the adjacent skin and areola of the
breast and bacteria, fungi or viral particles located in the newborn
nasopharyngeal tract, deriving from their direct environment. Some
bacterial transfer can also be explained by reverse flow from the
larger milk ducts near the nipple to smaller collecting ducts and
ductules (Ramsay et al., 2004). However, Urbaniak et al. also found
bacterial particles in breast samples which were taken from non-
lactating women during an operation (Urbaniak et al., 2016). Some
studies have suggested the origin of the human breast milk
microbiota is the maternal GIT, because the transfer of obligate
anaerobes such as Bifidobacterium breve which has been detected in
breast milk samples is not possible via skin contact (Jost et al., 2014).
If this was the case, bacteria in the intestinal lumen of the maternal
GIT could be taken up by immune cells, transferred via the blood
and/or lymphatic system and then secreted into the breast milk.
Such a connection between the maternal GIT microbiota and breast
milk production could be the key to new treatment opportunities in
lactating mothers.
In 2019, Togo et al. reported the successful cultivation of
methanogenic archaea from breast milk samples (Togo et al.,
2019). The amount of DNA was low with 2 log 10 copies DNA/
ml, but they are still suggested to be important commensals due
to their H2 reducing properties (Hansen et al., 2011; Bang and
Schmitz, 2015). Another driving force for human microbial
diversity which has been nearly overlooked for a long time is
the human phageome (Manrique et al., 2016). This highly
dynamic system creates a high predation pressure, may be
introduced with microbes in breast milk and shapes the
human microbiome (Rodriguez-Valera et al., 2009). There is
growing evidence that the maternal intestinal microbiota is an
important driver of breast milk composition, suggesting that new
interventions to optimize infant health could already start prior
or during pregnancy.
After the introduction of solid foods, the differences between
breast milk and formula fed infants become smaller and the
microbiota starts to resemble the adult microbiota (Backhed
et al., 2015). Some authors suggest that not the introduction of
solid food but rather the cessation of breast milk leads to the
alignment with the adult microbiota (Backhed et al., 2015; Levin
et al., 2016). Given the fact that the human diet seem so
decisively to influence microbial properties, the microbiota is
potentially ripe for therapeutic intervention (Ku et al., 2020),
especially during the newborn period.
INFLUENCE OF ANTIBIOTICS
Unfortunately, globally the incidence of infections remains high
in the newborn period (Fanos et al., 2007), and several diseases
affecting newborns necessitate the administration of broad
spectrum antibiotics (Isaacs, 2000; Gordon and Jeffery, 2005;
Clark et al., 2006). Pre- as well as peri- and postnatal antibiotic
therapy negatively influences the neonatal microbiota (Gibson
et al., 2015; Tapiainen et al., 2019) and consequently the
development of the infant’s immune system (Zeissig and
Blumberg, 2014). Antibiotic therapy is associated with a lower
number of commensal bacteria with delayed colonization with
Bifidobacteria and Bacteroidetes (Coker et al., 2020; Eck et al.,
2020) and a higher amount of potential pathogens (Aloisio et al.,
2016). However, attempts to restore a healthy microbiota with
probiotic treatment after antibiotic use even led to prolonged
dysbiosis in healthy volunteers (Suez et al., 2018). In a cohort of
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infants aged 2–36 months, Yassour et al. observed that antibiotic
treatment significantly reduced the strain diversity inducing a
less stable microbiota. Moreover, bacteria increasingly acquired
antibiotic resistance genes (Yassour et al., 2016). As such, the use
of antibiotics increase the probability of fungal overgrowth
(Kligman, 1952). Moreover, antibiotics may impact on long-
term health outcomes such as modified nutrient absorption
(Krajmalnik-Brown et al., 2012), lower vitamin production
(LeBlanc et al., 2013), higher incidence of obesity (Dawson-
Hahn and Rhee, 2019) and atopic diseases (Baron et al., 2020).
The aim is to protect this delicate balance of bacterial and
probably fungal interactions which support the healthy GIT-
microbiota (Peleg et al., 2010). Thereby, ending antibiotic
therapy expeditiously and narrowing antibiotic therapy should
be encouraged for infants that do require antibiotics.
DEVELOPMENT OF THE MICROBIOTA IN
EARLY CHILDHOOD
Despite huge individual differences (Eckburg et al., 2005; Ley
et al., 2006; Turnbaugh et al., 2009) the development of the
microbiota still follows typical timely changes as shown in
Figure 1. Directly after birth, healthy term infants have a
primarily aerobic GIT, which promotes the appearance of
facultative anaerobe bacteria such as Firmicutes (Enterococcus,
Staphylococcus, Streptococcus) and Proteobacteria (Enterobacter,
Escherichia coli) (Palmer et al., 2007; Del Chierico et al., 2015).
These bacteria reduce the oxygen content in the intestine and
facilitate the occurrence of obligate anaerobic bacteria such as
Actinobacteria (Bifidobacterium), Bacteroidetes (Bacteroides),
and Firmicutes (Clostridium, Lactobacillus, Ruminococcus)
(Koenig et al., 2011; Del Chierico et al., 2015). After three
months of life, Actinobacteria (Bifidobacterium), Bacteroidetes
(Bacteroides), and Proteobacteria (Escherichia) dominate the
intestinal tract (Fallani et al., 2011; Hill et al., 2017). After 12
months of life, the infant’s GIT is dominated by Actinobacteria
(Bifidobacterium, Collinsella) and Firmicutes (Lactobacillus,
Megasphaera, Veillonella) (Penders et al., 2006). After 2–3
years of age, children display a higher diversity and lower
inter-individual differences (Yatsunenko et al., 2012). The
microbiota stabilizes after about 3 years and then resembles
the adult microbiota in terms of diversity and complexity with
high abundance of species from the firmicutes and bacteroidetes
phyla (Arumugam et al., 2011).
DISCUSSION AND CONCLUSION
This review demonstrates that there is still a large knowledge gap
in regard to the microbial colonization of newborns. Neither the
authors of the “sterile womb hypothesis” nor those defending
the “in-utero colonization hypothesis” (Perez-Munoz et al.,
2017) are able to completely explain the signaling mechanisms
at the materno-fetal interface. Because the fetal intestinal
immune system develops as early as 16 weeks of pregnancy
FIGURE 1 | Summary of different factors and timely changes of the infant microbiome.
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(Stras et al., 2019) and fetal genetic particles have been found in
the maternal blood (Lo et al., 1990; Lo et al., 1997), we assume
that microbial particles derived from the mother are transported
to the fetal side as well. This “microbial priming” (Ganal-
Vonarburg et al., 2017) may help to prepare the offspring for
microbial contact after birth. It could also be triggered via the
transfer of bacterial, viral, archaeal or fungal components
through the blood, the interstitium, or immune cells.
Materno-fetal protein-transport and antigen-presentation has
been previously described, for example via the placental Fc-
receptors (Malek et al., 1998; Wilcox and Jones, 2018). Although
exosomes become increasingly attentive (Czernek and Duchler,
2020), it is unclear, whether microbial particles might also be
transferred via exosomes in healthy pregnancies.
The microbial seeding during the first days of life makes the
newborn highly susceptible to microbial perturbations (Bokulich
et al., 2016). The most important factors affecting microbial
seeding are gestational age, mode of delivery, nutrition, and
antibiotic therapy (Azad et al., 2016; Levin et al., 2016; Martin
et al., 2016). Optimizing nutrition and medical treatment could
potentially improve newborn growth, prevent NEC and support
favorable long-term outcomes. However, the molecular
mechanisms remain unclear. Additionally, most have used
human feces as a surrogate to study the intestinal microbiota,
although it is unknown to which extent the bacteria found in the
feces represent the microbiota of the GIT and whether the
luminal (transient) bacteria correlate with mucosal (resident)
bacteria, which might differ depending on the gastrointestinal
region (Sundin et al., 2020).
In summary, we are convinced that a deeper understanding of
the development of the newborn and infant microbiota will help
to discover further potentially modifying factors to improve
long-term health and quality of life.
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